Status: Recruiting
Nasal Antisepsis for C. Auris Prevention
This is a randomized, controlled, open-label trial of effect of 10% povidone iodine intranasal antisepsis on the detection of Candida auris.
Participants needed: 120
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Mary K HaydenUpdated: Oct 15, 2025Locations: 3
Eligibility criteria
History of C. auris colonization or infection [+1]
History of severe allergy to iodine-based products, defined as anaphylaxis or ra... [+2]